Events, Pharmaceutical

Aptar Pharma Highlights Innovative Drug Delivery Solutions at Cphi Europe

From October 24th to 26th, 2023, in Barcelona, Spain, Aptar Pharma will showcase our diverse portfolio of drug delivery systems, components, active packaging and digital health solutions.

By Carol Levasseur Senior Marketing Manager, Aptar Pharma
16 May 2023

Aptar Pharma highlights Innovative Drug Delivery Solutions at CPhI Europe

Aptar Pharma is delighted to announce its participation in the highly anticipated CPhI Europe event, scheduled to take place from October 24th to 26th, 2023, in Barcelona, Spain. As a leading provider of advanced drug delivery systems and solutions, we will present our diverse portfolio of products, including components, active packaging, and digital health solutions, at booth number #2K40 – Hall 2.

At the Aptar Pharma booth, attendees will have the opportunity to explore the latest breakthroughs in drug delivery systems across various routes, such as nasal, pulmonary, eye care, injectables, and dermal. Through these cutting-edge innovations, we aim to enhance patient experiences.

Key highlights of Aptar Pharma’s presence at CPhI Europe include:

  1. Commitment to Sustainability: Aptar Pharma is dedicated to delivering a more sustainable future, offering solutions that support a circular approach to healthcare.
  2. APF Futurity™: Aptar Pharma will unveil APF Futurity™, its groundbreaking metal-free and highly recyclable spray pump for nasal spray devices. This innovation reflects Aptar Pharma’s dedication to designing recyclable solutions.
  3. Expanded Capacity and Capabilities: Aptar Pharma is expanding its operations worldwide to meet the growing demands of its injectables. The expansion aims to increase capacity and introduce new capabilities to better serve pharmaceutical partners.
  4. Advancements in Pressurized Metered Dose Inhalers: Aptar Pharma’s end-to-end solutions using benchmark technologies support market leading developments of more sustainable pressurized metered dose inhalers (pMDIs) containing low GWP propellants. These advancements contribute to accelerate market access of pMDIs with a significantly reduced carbon footprint.
  5. Aptar Pharma Services: Aptar Pharma supports its customers in accelerating and derisking their drug development journey, from formulation to patient, through its comprehensive Aptar Pharma Services.
  6. Aptar Digital Health: Aptar Pharma provides continuous support and decentralized care to enhance patient experiences through Aptar Digital Health solutions.

In addition, Aptar CSP Technologies, a division of Aptar Pharma, will showcase its extensive portfolio of active material science solutions for protecting drug delivery systems. Experts will be available to discuss Aptar CSP’s Co-Development Program, which aims to accelerate and de-risk the drug development process.

To gain access to the exhibition halls, interested individuals can register online and receive a Free Access Pass.

Get the free access pass here

Aptar Pharma has been an active participant at CPhI for several years, and we eagerly anticipate meeting with customers and visitors at the event in Barcelona.

Back To Top